Financials
- Market Capitalization 3.68 B
- Employee 1 184
- Founded 2015
- CEO Christian Behrenbruch
- Website www.telixpharma.com
- Headquarter Australia
- FIGI BBG01N69K900
- Industry Biotechnologies
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1540 | DNLI Denali Therapeutics Inc. - Common Stock | 23.38 USD | -1.60% | -6.89% | +2.32% | +44.59% | 3.74 B USD | ||
| 1555 | IOVA Iovance Biotherapeutics, Inc. - Common Stock | 8.14 USD | -0.37% | -2.86% | +98.54% | +271.69% | 3.69 B USD | ||
| 1591 | VCYT Veracyte, Inc. - Common Stock | 43.08 USD | -0.25% | -0.69% | -7.08% | +16.75% | 3.46 B USD | ||
| 1595 | ABCL AbCellera Biologics Inc. - Common Shares | 11.27 USD | -1.83% | -7.62% | +97.72% | +174.88% | 3.46 B USD |